Katherine Szarama, PhD, named Acting CBER Director: who’s next?
Professor Paul Knoepfler, Ph.D.
Yesterday was Vinay Prasad’s last day as the Director of CBER, the FDA’s biologics branch and as of today Katherine Szarama is Acting Director. Is there some significance to Szarama being acting director? It’s hard to say. Most signs seem to suggest someone else will become the permanent leader. Katherine Szarama background From Politico: “Szarama […] The post Katherine Szarama, PhD, named Acting CBER Director: who’s next? appeared first on The Niche .